Navigation Links
TrialNetworks Sees Strong Growth in Demand for its Clinical Trial Optimization System as Pharma Seeks Technology to Improve Operations Quality and Efficiency
Date:11/7/2013

ck="linkClick(this.href)" rel="nofollow">Clinical Informatics News (featuring customer experiences from Merck & Co.) and Mass High Tech
  • 10,000th "commit" to source code repository for software updates and feature additions
  • TrialNetworks Co-Founder and CEO Eric Silberstein said, "Sponsors want to use the TrialNetworks platform because in a world of greater trial complexity and strategic outsourcing models, innovative technology is the best way to improve the transparency, quality and efficiency of clinical operations. As more people hear about the benefits of TrialNetworks and as we expand our apps we have seen demand from existing customers and prospective sponsors increase across the board – from biotechs without marketed products to top global pharmaceutical companies."

    About TrialNetworks

    TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using this modern and intuitive technology, customers such as Merck & Co. and Infinity Pharmaceuticals are able to transform the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist™, Training™, Document Library™, Visit Guide™, Action Items™ and Directory™, are available in a unified and secure cloud-based interface. Customers ranging from biotechs to Top-10 pharma companies have implemented the TrialNetworks platform for use in Phase I-IV trials by more than 25,000 site staff in 60 countries. To learn why sponsors and CROs rely on TrialNetworks to optimize clinical trial operations, request a guided online demo at

    Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. TrialNetworks Feasibility Survey™ App Gets ARIAD Pharmaceuticals Unprecedented 75% Response from Potential Clinical Trial Investigator Sites
    2. TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
    3. Terascala Closes Additional Funding Based on Strong OEM Sales and Release of ISB
    4. Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
    5. New SPIE Open Access Publishing Program Wins Strong Participation
    6. Industries Show Strong Support for 2B Monthly-The Global Biocontrol & Biostimulants Newsletter
    7. California Physical Therapy Association Strongly Supports the "Promoting Integrity in Medicare Act" to Fight Self-Referral of Physical Therapist Services
    8. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
    9. Bed Bugs Bum Rides on Taxis, Use of Non-Pesticide Bed Bug Spray Recommended by My Cleaning Products to Kill the Pests Without Strong Chemicals' Help
    10. UNL teams discovery yields supertough, strong nanofibers
    11. NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/26/2014)... August 26, 2014 New research ... wearable technology, and inspiration for the International Year ... year’s brighter, busier SPIE Optics + Photonics ... More than 4,400 international scientists, engineers, researchers, developers, ... exhibition, and industry sessions sponsored by SPIE, ...
    (Date:8/26/2014)... team of engineers from Singapore has successfully piloted ... for satellite communications. , With the weight of ... constructing a lightweight, low power-consuming, wireless communication system ... has always been a challenge for system designers. ... Centre of Nanyang Technological University in Singapore launched ...
    (Date:8/26/2014)... Aug. 26, 2014 An analysis by Replikins, ... all Dengue virus strains in Pubmed, has revealed extensive ... 1944. This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
    (Date:8/26/2014)... , Aug. 26, 2014 Technology Applications ... symbol (NUUU) has two (2) wholly- owned subsidiaries, ... subsidiaries harness scientifically advanced technology to provide advanced ... NUUU,s Renuell Int,l, Inc. is launching its ... care products that is made possible because of ...
    Breaking Biology Technology:Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 4ZigBee in the Sky 2Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2
    ... the, prior year,s third quarter - Earnings per share of $0.28, ... cash flow of $23 million, (Year-to-date operating cash flow of $62 million) ... ... Biosciences,Corporation (Nasdaq: MATK ) today announced its financial results for the,third ...
    ... The Hamner Institutes and The University of North Carolina-Chapel ... Research Partnership in Drug Safety Sciences, RESEARCH TRIANGLE ... Sciences and the University of North Carolina at,Chapel Hill ... Safety,Sciences that will be led by Dr. Paul Watkins, ...
    ... /Xinhua-PRNewswire-FirstCall/ -- Genesis,Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: ... in the People,s Republic,of China, today announced that ... common stock which will begin trading under the ... common stock will no longer trade,under the symbol ...
    Cached Biology Technology:Martek Announces Third Quarter 2008 Financial Results 2Martek Announces Third Quarter 2008 Financial Results 3Martek Announces Third Quarter 2008 Financial Results 4Martek Announces Third Quarter 2008 Financial Results 5Martek Announces Third Quarter 2008 Financial Results 6Martek Announces Third Quarter 2008 Financial Results 7Martek Announces Third Quarter 2008 Financial Results 8Martek Announces Third Quarter 2008 Financial Results 9Martek Announces Third Quarter 2008 Financial Results 10New Hamner-UNC Center for Drug Safety Sciences 2New Hamner-UNC Center for Drug Safety Sciences 3Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 2Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 3
    (Date:8/27/2014)... A growing number of studies have shown ... the pathogenesis of Parkinson,s disease. Previous studies ... Medical University in China have shown that ... injury, reduced divalent metal transporter 1 expression, ... substantia nigra of rotenone-induced Parkinson,s disease rats. ...
    (Date:8/27/2014)... Happy Camp Complex of fires had consumed 24,939 acres ... consumed 35,530 as of eight hours ago. , ... Ranger District of the Klamath National Forest when a ... All but three of those fires are now 100 ... fires and their size at containment: Delta, 150 acres; ...
    (Date:8/27/2014)... Carolina State University have found that century-old museum specimens hold ... insect pest that can weaken and kill trees and ... scale insect populations increase on oak and maple trees in ... may also increase with global warming," says Dr. Elsa Youngsteadt, ... a paper on the work. , "More scale insects would ...
    Breaking Biology News(10 mins):Happy Camp and July Fire Complexes in California 2Museum specimens, modern cities show how an insect pest will respond to climate change 2
    ... and microorganisms, Systems Biology is regarded as the next ... allow biologists to spell all the letters in the ... way of deciphering this complex code. Pharma- and biotechnology ... tools for use in drug discovery and development., Systems ...
    ... cells, high school students and teachers sounds like a witches brew ... Instead, these are the components that ... curriculum being developed by researchers at Washington University in St. Louis ... Lars Angenent, Ph.D., assistant ...
    ... Commonwealth University Massey Cancer Center research team has received ... National Cancer Institute to improve the activity of a ... in the treatment of leukemia and other blood malignancies. ... associate director for translational research and co-leader of the ...
    Cached Biology News:World class in Systems Biology is the aim 2World class in Systems Biology is the aim 3World class in Systems Biology is the aim 4Microbial fuel cells turn on the juice 2Microbial fuel cells turn on the juice 3NCI renewal grant to develop new cancer therapies 2
    ...
    12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
    Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
    No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
    Biology Products: